Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 1Sarcoma 1

Conditions

Sarcoma 4Pleural Neoplasms 1Neoplasm Metastasis 1Mediastinal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 4pembrolizumab 3Irinotecan 3Carboplatin 3Specimen Handling 2Radiosurgery 2Psychiatric Rehabilitation 2Observation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Floxuridine 2Erlotinib Hydrochloride 2Cyclophosphamide 2Cetuximab 2Bortezomib 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1spartalizumab 1sodium thiosulfate 1selpercatinib 1rucaparib 1repotrectinib 1pidilizumab 1pazopanib 1p53 peptide 264-272, human 1motexafin lutetium 1montanide ISA 51 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Mitomycin × Sarcoma × Clear all
NCT05672108 2026-03-05

Phase II Trial of Lung Chemoemobolization

City of Hope Medical Center

Phase 2 Recruiting
30 enrolled
GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Mediastinal Neoplasms, Pleural Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡